Certified by Founder Lodge
SURGE Therapeutics
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $32,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
SURGE seeks to dramatically improve cancer patient survival by disrupting how, when, and where cancer immunotherapy is deployed -- focusing 100% of the effective dose at the right place and a
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 20 ,2023 | Series B | $32,000,000 |
Intuitive Ventures
8VC
KdT Ventures
Pitango
Camford Capital
Piedmont Capital
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
